as 06-18-2025 4:00pm EST
Stocks
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Founded: | 2010 | Country: | United States |
Employees: | N/A | City: | BURLINGTON |
Market Cap: | 58.8M | IPO Year: | 2024 |
Target Price: | $10.00 | AVG Volume (30 days): | 362.1K |
Analyst Decision: | Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.84 | EPS Growth: | N/A |
52 Week Low/High: | $0.87 - $5.50 | Next Earning Date: | 05-13-2025 |
Revenue: | $60,000 | Revenue Growth: | -59.46% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
GUTS Breaking Stock News: Dive into GUTS Ticker-Specific Updates for Smart Investing
MT Newswires
11 hours ago
GlobeNewswire
13 hours ago
TipRanks
5 days ago
GlobeNewswire
6 days ago
GlobeNewswire
15 days ago
MT Newswires
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
The information presented on this page, "GUTS FRACTYL HEALTH INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.